Cosmetic cross-reference Noindex: medium evidence

Acid Blue 3

CAS 3536-49-0

Acid Blue 3 (CAS 3536-49-0) is a pharmaceutical compound with 0 bioactivity targets and 1 adverse event association.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
0
SOURCE DrugCentral
Adverse signals
1
SOURCE IUPHAR/BPS
PubMed IDs
0
SOURCE EPA DSSTox

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
Acid Blue 3
CAS Number
3536-49-0
Molecular Formula
2C27H32N2O7S2.Ca
InChIKey
RTMBGDBBDQKNNZ-UHFFFAOYSA-L
Source Match
EPA DSSTox
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

SOURCE DSSTox identifiers DTXSID00873918

Cross-Reference to Chemicals

Same-CAS substance identity is available in the industrial chemicals vertical.

Acid Blue 3 is linked to DTXSID00873918 in DSSTox identifiers.

View industrial chemical data →
SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Acid Blue 3 used for in pharmaceutical contexts?

Acid Blue 3 (CAS 3536-49-0) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Acid Blue 3?

Acid Blue 3 has 1 DrugCentral/FAERS adverse event association. Rendered reaction terms include Anaphylactic shock. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Acid Blue 3 also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for CI 42051 (Patent Blue V / Acid Blue 3) with EU status "restricted".

What clinical phase is Acid Blue 3 in?

No phase 1-4 clinical development badge is rendered for Acid Blue 3 because the matched compound identifier rows do not contain a max-phase value.